Arcus Biosciences | ARS: Annual Report to Security Holders
Apr 24 18:03
Arcus Biosciences | DEFA14A: Others
Apr 24 04:16
Arcus Biosciences | DEF 14A: Definitive information statements
Apr 24 04:11
Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jarrett Jennifer
Mar 30 04:24
Arcus Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 28 04:16
Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jarrett Jennifer
Mar 21 04:24
Arcus Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 16 04:36
Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jarrett Jennifer
Feb 29 08:59
Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jaen Juan C.
Feb 29 08:59
Arcus Biosciences | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Goeltz II Robert C.
Feb 24 06:55
Arcus Biosciences | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 22 05:57
Arcus Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 22 05:40
Arcus Biosciences | 10-K: Annual report
Feb 22 05:21
Arcus Biosciences | 8-K: Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
Feb 22 05:14
Arcus Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.25%)
Feb 14 11:58
Arcus Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.317%),Abigail P. Johnson(6.317%)
Feb 9 21:40
Arcus Biosciences | 3: Initial statement of beneficial ownership of securities-Director Mercier Johanna
Feb 8 08:02
Arcus Biosciences | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Feb 1 06:04
Arcus Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Gilead Sciences, Inc.(35%)
Feb 1 06:03
Arcus Biosciences | 8-K: Current report
Jan 30 21:22
No Data
No Data